Dr. Marcelo L. Hochman, MD

Dr. Hochman practices at MUSC Physicians in Mount Pleasant, South Carolina.

Dr. Hochman's NPI, 1780797449, was assigned on August 16, 2006. Dr. Hochman graduated from Joe R. & Teresa Lozano Long School of Medicine in 1985. Dr. Hochman holds South Carolina license 15785.

Dr. Hochman's primary practice is MUSC Physicians, at 1208 2 Island Ct, Mount Pleasant, SC 29466 in Charleston County. The practice phone is (803) 286-4666.

Dr. Hochman's primary practice is MUSC Physicians in Mount Pleasant, South Carolina. Dr. Hochman is also affiliated with MUSC Health University Medical Center. The medical group on file is MUSC Health. Dmand AI also links Dr. Hochman to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hochman practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Hochman's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Hochman is board certified in facial plastic and reconstructive surgery by the American Board of Facial Plastic and Reconstructive Surgery. Dmand AI has Dr. Hochman's licenses on file in 2 states: South Carolina and Arkansas.

Dmand AI lists head wound among the conditions Dr. Hochman treats.

CMS data shows 47 Medicare services from Dr. Hochman across 3 procedure codes in 2024, all of them office visits, for 45 Medicare patients. Medicare paid $2,638 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Dr. Hochman in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high cholesterol, and 58% have high blood pressure. Their average risk score is 0.73, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hochman's median patient age at 2, with 65% women.

In 2024, Dr. Hochman wrote 212 Medicare Part D claims for 56 patients. 98% of them were for generic drugs. CMS names the drug for 152 of them, across 4 drugs with 11 or more claims each, at $545 in total drug cost. In 2023, CMS named 198 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Hochman for performance year 2024, reported as part of a group. Dr. Hochman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Hochman, published from 2011 to 2024. 2023 was the busiest year, with 3. The most frequent topics are Hemangioma, Port-Wine Stain and Vascular Malformations. Dr. Hochman has published most often in Arch Facial Plast Surg. Dr. Hochman's most frequent co-authors are Elliott Ho Chen, MD, Harold L. Friedman, MD and Ladan Enayati.

CMS Open Payments shows 61 general payments to Dr. Hochman from 19 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 81% of the total. Pierre Fabre Pharmaceuticals, Inc. paid the most, $16,958.

Dmand AI lists 26 awards for Dr. Hochman, most recently America’s Top Surgeons, Facial Plastic Surgery in 2017.

Dr. Hochman graduated from Joe R. & Teresa Lozano Long School of Medicine in 1985. Dr. Hochman is a member of AAFPRS, NHS, AMA, American Society for Laser Medicine and Surgery, International Society for the Study of Vascular Anomalies and North Carolina/South Carolina Otolaryngology Society.